ImmunityBio, Inc. IBRX Short- term Investments
Short- term Investments at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s short- term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s short- term investments?
- ImmunityBio, Inc. (IBRX) reported short- term investments of $175.69M in Q1 2026.
- How has ImmunityBio, Inc.'s short- term investments changed year-over-year?
- ImmunityBio, Inc.'s short- term investments increased by 18770.6% year-over-year, from $931K to $175.69M.
- What is the long-term trend for ImmunityBio, Inc.'s short- term investments?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s short- term investments has grown at a 20.4% compound annual growth rate (CAGR), from $61.15M to $154.48M.